Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ataxin-2 (Homo sapiens (Human)) | BDBM352271![]() (5-((3aS,6aS)-5-(5-Cyclopropyl-6-(tetrahydro-2H-pyr...) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US9802944 (2017) BindingDB Entry DOI: 10.7270/Q2SF2Z9M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM352340![]() (US9802944, Example 2.01) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US9802944 (2017) BindingDB Entry DOI: 10.7270/Q2SF2Z9M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM352339![]() (4-((3aR,6aS)-5-(5-Cyclopropyl-6-(tetrahydro-2H-pyr...) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US9802944 (2017) BindingDB Entry DOI: 10.7270/Q2SF2Z9M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM352271![]() (5-((3aS,6aS)-5-(5-Cyclopropyl-6-(tetrahydro-2H-pyr...) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US9802944 (2017) BindingDB Entry DOI: 10.7270/Q2SF2Z9M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM352349![]() (US9802944, Example 2.06) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US9802944 (2017) BindingDB Entry DOI: 10.7270/Q2SF2Z9M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM352366![]() (US9802944, Example 2.23) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US9802944 (2017) BindingDB Entry DOI: 10.7270/Q2SF2Z9M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM352339![]() (4-((3aR,6aS)-5-(5-Cyclopropyl-6-(tetrahydro-2H-pyr...) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US9802944 (2017) BindingDB Entry DOI: 10.7270/Q2SF2Z9M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM352271![]() (5-((3aS,6aS)-5-(5-Cyclopropyl-6-(tetrahydro-2H-pyr...) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US9802944 (2017) BindingDB Entry DOI: 10.7270/Q2SF2Z9M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM352388![]() (((3aR,8aS)-6-(2-Cyclopropyl-6-((tetrahydro-2H-pyra...) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US9802944 (2017) BindingDB Entry DOI: 10.7270/Q2SF2Z9M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM352271![]() (5-((3aS,6aS)-5-(5-Cyclopropyl-6-(tetrahydro-2H-pyr...) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US9802944 (2017) BindingDB Entry DOI: 10.7270/Q2SF2Z9M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM352271![]() (5-((3aS,6aS)-5-(5-Cyclopropyl-6-(tetrahydro-2H-pyr...) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 6 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US9802944 (2017) BindingDB Entry DOI: 10.7270/Q2SF2Z9M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM352389![]() (1H-Triazol-4-ylmethyl (3aS,8aR)-6-[2-cyclopropyl-6...) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 6 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US9802944 (2017) BindingDB Entry DOI: 10.7270/Q2SF2Z9M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM352382![]() (((3aR,6aR)-5-(2-Cyclopropyl-6-((tetrahydro-2H-pyra...) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 6 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US9802944 (2017) BindingDB Entry DOI: 10.7270/Q2SF2Z9M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM352364![]() (US9802944, Example 2.21) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 6 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US9802944 (2017) BindingDB Entry DOI: 10.7270/Q2SF2Z9M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM352271![]() (5-((3aS,6aS)-5-(5-Cyclopropyl-6-(tetrahydro-2H-pyr...) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 6 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US9802944 (2017) BindingDB Entry DOI: 10.7270/Q2SF2Z9M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM352357![]() (US9802944, Example 2.14) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 6 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US9802944 (2017) BindingDB Entry DOI: 10.7270/Q2SF2Z9M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM352271![]() (5-((3aS,6aS)-5-(5-Cyclopropyl-6-(tetrahydro-2H-pyr...) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 7 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US9802944 (2017) BindingDB Entry DOI: 10.7270/Q2SF2Z9M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM352371![]() (US9802944, Example 2.28) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 7 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US9802944 (2017) BindingDB Entry DOI: 10.7270/Q2SF2Z9M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM352382![]() (((3aR,6aR)-5-(2-Cyclopropyl-6-((tetrahydro-2H-pyra...) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 7 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US9802944 (2017) BindingDB Entry DOI: 10.7270/Q2SF2Z9M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM352271![]() (5-((3aS,6aS)-5-(5-Cyclopropyl-6-(tetrahydro-2H-pyr...) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 7 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US9802944 (2017) BindingDB Entry DOI: 10.7270/Q2SF2Z9M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM352271![]() (5-((3aS,6aS)-5-(5-Cyclopropyl-6-(tetrahydro-2H-pyr...) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 7 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US9802944 (2017) BindingDB Entry DOI: 10.7270/Q2SF2Z9M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM352372![]() (US9802944, Example 2.29) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 7 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US9802944 (2017) BindingDB Entry DOI: 10.7270/Q2SF2Z9M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM352382![]() (((3aR,6aR)-5-(2-Cyclopropyl-6-((tetrahydro-2H-pyra...) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 7 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US9802944 (2017) BindingDB Entry DOI: 10.7270/Q2SF2Z9M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM352271![]() (5-((3aS,6aS)-5-(5-Cyclopropyl-6-(tetrahydro-2H-pyr...) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 8 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US9802944 (2017) BindingDB Entry DOI: 10.7270/Q2SF2Z9M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM352271![]() (5-((3aS,6aS)-5-(5-Cyclopropyl-6-(tetrahydro-2H-pyr...) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 8 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US9802944 (2017) BindingDB Entry DOI: 10.7270/Q2SF2Z9M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM352271![]() (5-((3aS,6aS)-5-(5-Cyclopropyl-6-(tetrahydro-2H-pyr...) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 9 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US9802944 (2017) BindingDB Entry DOI: 10.7270/Q2SF2Z9M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM352271![]() (5-((3aS,6aS)-5-(5-Cyclopropyl-6-(tetrahydro-2H-pyr...) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 9 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US9802944 (2017) BindingDB Entry DOI: 10.7270/Q2SF2Z9M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM352354![]() (US9802944, Example 2.11) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 9 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US9802944 (2017) BindingDB Entry DOI: 10.7270/Q2SF2Z9M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM352271![]() (5-((3aS,6aS)-5-(5-Cyclopropyl-6-(tetrahydro-2H-pyr...) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 9 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US9802944 (2017) BindingDB Entry DOI: 10.7270/Q2SF2Z9M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM352360![]() (US9802944, Example 2.17) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 9 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US9802944 (2017) BindingDB Entry DOI: 10.7270/Q2SF2Z9M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM352382![]() (((3aR,6aR)-5-(2-Cyclopropyl-6-((tetrahydro-2H-pyra...) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 10 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US9802944 (2017) BindingDB Entry DOI: 10.7270/Q2SF2Z9M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM352361![]() (US9802944, Example 2.18) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 10 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US9802944 (2017) BindingDB Entry DOI: 10.7270/Q2SF2Z9M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM352342![]() (US9802944, Example 2.03) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 10 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US9802944 (2017) BindingDB Entry DOI: 10.7270/Q2SF2Z9M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM352356![]() (US9802944, Example 2.13) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 10 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US9802944 (2017) BindingDB Entry DOI: 10.7270/Q2SF2Z9M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM352362![]() (US9802944, Example 2.19) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 10 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US9802944 (2017) BindingDB Entry DOI: 10.7270/Q2SF2Z9M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM352365![]() (US9802944, Example 2.22) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 10 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US9802944 (2017) BindingDB Entry DOI: 10.7270/Q2SF2Z9M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM352350![]() (US9802944, Example 2.07 | US9802944, Example 2.09) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 10 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US9802944 (2017) BindingDB Entry DOI: 10.7270/Q2SF2Z9M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM352348![]() (US9802944, Example 2.05) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 10.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US9802944 (2017) BindingDB Entry DOI: 10.7270/Q2SF2Z9M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM352367![]() (US9802944, Example 2.24) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 11 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US9802944 (2017) BindingDB Entry DOI: 10.7270/Q2SF2Z9M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM352355![]() (US9802944, Example 2.12) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 11 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US9802944 (2017) BindingDB Entry DOI: 10.7270/Q2SF2Z9M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM352374![]() (6-((3aS,6aS)-5-(5-Cyclopropyl-6-(tetrahydro-2H-pyr...) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 12 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US9802944 (2017) BindingDB Entry DOI: 10.7270/Q2SF2Z9M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM352358![]() (US9802944, Example 2.15) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 12 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US9802944 (2017) BindingDB Entry DOI: 10.7270/Q2SF2Z9M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM352271![]() (5-((3aS,6aS)-5-(5-Cyclopropyl-6-(tetrahydro-2H-pyr...) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 13 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US9802944 (2017) BindingDB Entry DOI: 10.7270/Q2SF2Z9M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM352271![]() (5-((3aS,6aS)-5-(5-Cyclopropyl-6-(tetrahydro-2H-pyr...) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 14 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US9802944 (2017) BindingDB Entry DOI: 10.7270/Q2SF2Z9M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM352271![]() (5-((3aS,6aS)-5-(5-Cyclopropyl-6-(tetrahydro-2H-pyr...) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 14 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US9802944 (2017) BindingDB Entry DOI: 10.7270/Q2SF2Z9M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM352369![]() (US9802944, Example 2.26) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 14 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US9802944 (2017) BindingDB Entry DOI: 10.7270/Q2SF2Z9M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM352271![]() (5-((3aS,6aS)-5-(5-Cyclopropyl-6-(tetrahydro-2H-pyr...) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 15 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US9802944 (2017) BindingDB Entry DOI: 10.7270/Q2SF2Z9M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM352382![]() (((3aR,6aR)-5-(2-Cyclopropyl-6-((tetrahydro-2H-pyra...) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 16 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US9802944 (2017) BindingDB Entry DOI: 10.7270/Q2SF2Z9M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM352382![]() (((3aR,6aR)-5-(2-Cyclopropyl-6-((tetrahydro-2H-pyra...) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 16 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US9802944 (2017) BindingDB Entry DOI: 10.7270/Q2SF2Z9M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM352341![]() (US9802944, Example 2.02) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 17 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US9802944 (2017) BindingDB Entry DOI: 10.7270/Q2SF2Z9M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM352359![]() (US9802944, Example 2.16) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 17 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US9802944 (2017) BindingDB Entry DOI: 10.7270/Q2SF2Z9M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM352368![]() (US9802944, Example 2.25) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 17 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US9802944 (2017) BindingDB Entry DOI: 10.7270/Q2SF2Z9M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM352271![]() (5-((3aS,6aS)-5-(5-Cyclopropyl-6-(tetrahydro-2H-pyr...) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 17 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US9802944 (2017) BindingDB Entry DOI: 10.7270/Q2SF2Z9M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM352271![]() (5-((3aS,6aS)-5-(5-Cyclopropyl-6-(tetrahydro-2H-pyr...) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 19 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US9802944 (2017) BindingDB Entry DOI: 10.7270/Q2SF2Z9M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM352370![]() (US9802944, Example 2.27) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 19 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US9802944 (2017) BindingDB Entry DOI: 10.7270/Q2SF2Z9M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM352380![]() (6-(((3aS,6aS)-5-(5-Cyclopropyl-6-(tetrahydro-2H-py...) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 19 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US9802944 (2017) BindingDB Entry DOI: 10.7270/Q2SF2Z9M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM352271![]() (5-((3aS,6aS)-5-(5-Cyclopropyl-6-(tetrahydro-2H-pyr...) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 20 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US9802944 (2017) BindingDB Entry DOI: 10.7270/Q2SF2Z9M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM352350![]() (US9802944, Example 2.07 | US9802944, Example 2.09) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 20 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US9802944 (2017) BindingDB Entry DOI: 10.7270/Q2SF2Z9M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM352271![]() (5-((3aS,6aS)-5-(5-Cyclopropyl-6-(tetrahydro-2H-pyr...) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 22 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US9802944 (2017) BindingDB Entry DOI: 10.7270/Q2SF2Z9M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM352374![]() (6-((3aS,6aS)-5-(5-Cyclopropyl-6-(tetrahydro-2H-pyr...) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 25 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US9802944 (2017) BindingDB Entry DOI: 10.7270/Q2SF2Z9M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM352374![]() (6-((3aS,6aS)-5-(5-Cyclopropyl-6-(tetrahydro-2H-pyr...) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 25 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US9802944 (2017) BindingDB Entry DOI: 10.7270/Q2SF2Z9M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM352271![]() (5-((3aS,6aS)-5-(5-Cyclopropyl-6-(tetrahydro-2H-pyr...) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 29 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US9802944 (2017) BindingDB Entry DOI: 10.7270/Q2SF2Z9M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM352271![]() (5-((3aS,6aS)-5-(5-Cyclopropyl-6-(tetrahydro-2H-pyr...) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 32 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US9802944 (2017) BindingDB Entry DOI: 10.7270/Q2SF2Z9M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM352380![]() (6-(((3aS,6aS)-5-(5-Cyclopropyl-6-(tetrahydro-2H-py...) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 39 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US9802944 (2017) BindingDB Entry DOI: 10.7270/Q2SF2Z9M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM352346![]() (US9802944, Example 2.04) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 40 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US9802944 (2017) BindingDB Entry DOI: 10.7270/Q2SF2Z9M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM352363![]() (US9802944, Example 2.20) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 40 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US9802944 (2017) BindingDB Entry DOI: 10.7270/Q2SF2Z9M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM352351![]() (US9802944, Example 2.08) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 68.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US9802944 (2017) BindingDB Entry DOI: 10.7270/Q2SF2Z9M | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Ataxin-2 (Homo sapiens (Human)) | BDBM352339![]() (4-((3aR,6aS)-5-(5-Cyclopropyl-6-(tetrahydro-2H-pyr...) | UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 91 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc US Patent | Assay Description ATX inhibition was measured by a fluorescence quenching assay using a specifically labeled substrate analogue (MR121 substrate). To obtain this MR121... | US Patent US9802944 (2017) BindingDB Entry DOI: 10.7270/Q2SF2Z9M | |||||||||||
More data for this Ligand-Target Pair |